StockData
Medline Inc. logo

Medline Inc. (MDLN) stock

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3068% above fair value
$39.16+1.48 (+3.93%)

Close on Nov 18, 2026Market cap $51.48BP/E –Yield –

Medline free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Medline's free cash flow for the twelve months ending Sep 26, 2026 was $1.90B. For fiscal 2025 it was $1.30B, down 8.3% from the year before.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.30B-8.3%
FY2024Dec 31, 2024$1.42B+0.4%
FY2023Dec 31, 2023$1.41B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$884.00M+65.2%
Q2 FY2026Jun 27, 2026$604.00M+594.3%
Q1 FY2026Mar 28, 2026$316.00M-45.9%
Q4 FY2025Dec 31, 2025$91.00M–
Q3 FY2025Sep 27, 2025$535.00M–
Q2 FY2025Jun 28, 2025$87.00M–
Q1 FY2025Mar 29, 2025$584.00M–

More Medline figures

See a number that looks wrong?